{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:32:50Z","timestamp":1772119970880,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institutes of Health\u2019s Environmental Health Sciences","award":["T32 ES007091"],"award-info":[{"award-number":["T32 ES007091"]}]},{"name":"National Institutes of Health\u2019s Environmental Health Sciences","award":["T32 ES007091"],"award-info":[{"award-number":["T32 ES007091"]}]},{"name":"National Institutes of Health\u2019s National Heart, Lung, and Blood Institute","award":["K01HL143137"],"award-info":[{"award-number":["K01HL143137"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12012-024-09895-w","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:01:52Z","timestamp":1721174512000},"page":"968-981","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of Metal Cations with the Anti-PF4\/Heparin Antibody Response in Heparin-Induced Thrombocytopenia"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8885-7292","authenticated-orcid":false,"given":"Jason B.","family":"Giles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiana L.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi E.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aikseng","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Pryor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8117-6678","authenticated-orcid":false,"given":"Nancy","family":"Sweitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-3334","authenticated-orcid":false,"given":"Jason H.","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"9895_CR1","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","volume":"129","author":"GM Arepally","year":"2017","unstructured":"Arepally, G. M. (2017). Heparin-induced thrombocytopenia. Blood, 129, 2864\u20132872.","journal-title":"Blood"},{"key":"9895_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1042\/bj3120357","volume":"312","author":"KH Mayo","year":"1995","unstructured":"Mayo, K. H., Ilyina, E., Roongta, V., Dundas, M., Joseph, J., Lai, C. K., Maione, T., & Daly, T. J. (1995). Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: Arginine residues are crucial for binding. Biochemical Journal, 312, 357\u2013365.","journal-title":"Biochemical Journal"},{"key":"9895_CR3","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1182\/blood.V83.11.3232.3232","volume":"83","author":"J Kelton","year":"1994","unstructured":"Kelton, J., Smith, J., Warkentin, T., Hayward, C., Denomme, G., & Horsewood, P. (1994). Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood, 83, 3232\u20133239.","journal-title":"Blood"},{"key":"9895_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-9560-3-14","volume":"3","author":"M Franchini","year":"2005","unstructured":"Franchini, M. (2005). Heparin-induced thrombocytopenia: An update. Thrombosis Journal, 3, 14.","journal-title":"Thrombosis Journal"},{"key":"9895_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/postgradmedj-2018-135702","volume":"94","author":"M Prince","year":"2018","unstructured":"Prince, M., & Wenham, T. (2018). Heparin-induced thrombocytopaenia. Postgraduate Medical Journal, 94, 453\u2013457.","journal-title":"Postgraduate Medical Journal"},{"key":"9895_CR6","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","volume":"10","author":"J Perdomo","year":"2019","unstructured":"Perdomo, J., Leung, H. H. L., Ahmadi, Z., Yan, F., Chong, J. J. H., Passam, F. H., & Chong, B. H. (2019). Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nature Communications, 10, 1322.","journal-title":"Nature Communications"},{"key":"9895_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1160\/TH16-02-0162","volume":"116","author":"D Madeeva","year":"2016","unstructured":"Madeeva, D., Cines, D. B., Poncz, M., & Rauova, L. (2016). Role of monocytes and endothelial cells in heparin-induced thrombocytopenia. Thrombosis and Haemostasis, 116, 806\u2013812.","journal-title":"Thrombosis and Haemostasis"},{"key":"9895_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/ATVBAHA.120.315445","volume":"41","author":"GM Arepally","year":"2020","unstructured":"Arepally, G. M., & Padmanabhan, A. (2020). Heparin-induced thrombocytopenia. Arteriosclerosis, Thrombosis, and Vascular Biology, 41, 141\u2013152.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"9895_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7196\/SAMJ.2021.v111i9.15909","volume":"111","author":"J Bailly","year":"2021","unstructured":"Bailly, J., Haupt, L., Joubert, J., Loebenberg, P., Jacobson, B. F., Louw, V. J., Wessels, P. F., & Opie, J. J. (2021). Heparin-induced thrombocytopenia: An update for the COVID-19 era. South African Medical Journal, 111, 841.","journal-title":"South African Medical Journal"},{"key":"9895_CR10","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","volume":"98","author":"MP Reilly","year":"2001","unstructured":"Reilly, M. P., Taylor, S. M., Hartman, N. K., Arepally, G. M., Sachais, B. S., Cines, D. B., Poncz, M., & McKenzie, S. E. (2001). Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through Fc\u03b3RIIA. Blood, 98, 2442\u20132447.","journal-title":"Blood"},{"key":"9895_CR11","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","volume":"106","author":"N Martel","year":"2005","unstructured":"Martel, N., Lee, J., & Wells, P. S. (2005). Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis. Blood, 106, 2710\u20132715.","journal-title":"Blood"},{"key":"9895_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1358863X19898253","volume":"25","author":"M Hogan","year":"2020","unstructured":"Hogan, M., & Berger, J. S. (2020). Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management. Vascular Medicine, 25, 160\u2013173.","journal-title":"Vascular Medicine"},{"key":"9895_CR13","doi-asserted-by":"crossref","unstructured":"Downs, E., Goldman, S., Palkimas, S., & Sharma, A. M. (2018). Heparin-induced thrombocytopenia (pp. 359\u2013390). Springer.","DOI":"10.1007\/978-3-319-73709-6_17"},{"key":"9895_CR14","doi-asserted-by":"crossref","unstructured":"Liu, R., Ren, C., Fu, M., Chu, Z., & Guo, J. (2022). Platelet detection based on improved YOLO_v3. Cyborg and Bionic Systems.","DOI":"10.34133\/2022\/9780569"},{"key":"9895_CR15","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2217\/pgs-2018-0147","volume":"19","author":"JH Karnes","year":"2018","unstructured":"Karnes, J. H. (2018). Pharmacogenetics to prevent heparin-induced thrombocytopenia: What do we know? Pharmacogenomics, 19, 1413\u20131422.","journal-title":"Pharmacogenomics"},{"key":"9895_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood.2021014240","volume":"240","author":"JH Karnes","year":"2022","unstructured":"Karnes, J. H., Rollin, J., Giles, J. B., Martinez, K. L., Steiner, H. E., Shaffer, C. M., Momozawa, Y., Inai, C., Bombin, A., Shi, M., Mosley, J. D., Stanaway, I., Selleng, K., Thiele, T., Mushiroda, T., Pouplard, C., Heddle, N. M., Kubo, M., Phillips, E. J., \u2026 Roden, D. M. (2022). ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia. Blood, 240, 274\u2013284.","journal-title":"Blood"},{"key":"9895_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1365-2141.1995.tb05383.x","volume":"91","author":"JK Burgess","year":"1995","unstructured":"Burgess, J. K., Lindeman, R., Chesterman, C. N., & Chong, B. H. (1995). Single amino acid mutation of FC\u03b3 receptor is associated with the development of heparin-induced thrombocytopenia. British Journal of Haematology, 91, 761\u2013766.","journal-title":"British Journal of Haematology"},{"key":"9895_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1182\/blood.V89.2.370","volume":"89","author":"G Arepally","year":"1997","unstructured":"Arepally, G., McKenzie, S. E., Jiang, X.-M., Poncz, M., & Cines, D. B. (1997). Fc\u03b3RIIA H\/R131 polymorphism, subclass-specific IgG anti-heparin\/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood, 89, 370\u2013375.","journal-title":"Blood"},{"key":"9895_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.thromres.2011.09.033","volume":"129","author":"C Pouplard","year":"2012","unstructured":"Pouplard, C., Cornillet-Lefebvre, P., Attaoua, R., Leroux, D., Lecocq-Lafon, C., Rollin, J., Grigorescu, F., Nguyen, P., & Gruel, Y. (2012). Interleukin-10 promoter microsatellite polymorphisms influence the immune response to heparin and the risk of heparin-induced thrombocytopenia. Thrombosis Research, 129, 465\u2013469.","journal-title":"Thrombosis Research"},{"key":"9895_CR20","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1182\/blood-2012-04-424044","volume":"120","author":"J Rollin","year":"2012","unstructured":"Rollin, J., Pouplard, C., Gratacap, M.-P., Leroux, D., May, M.-A., Aupart, M., Gouilleux-Gruart, V., Payrastre, B., & Gruel, Y. (2012). Polymorphisms of protein tyrosine phosphatase CD148 influence Fc\u03b3RIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia. Blood, 120, 1309\u20131316.","journal-title":"Blood"},{"key":"9895_CR21","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1182\/blood-2014-09-594515","volume":"125","author":"J Rollin","year":"2015","unstructured":"Rollin, J., Pouplard, C., Sung, H. C., Leroux, D., Saada, A., Gouilleux-Gruart, V., Thibault, G., & Gruel, Y. (2015). Increased risk of thrombosis in FcgammaRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2. Blood, 125, 2397\u20132404.","journal-title":"Blood"},{"key":"9895_CR22","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","volume":"96","author":"TE Warkentin","year":"2000","unstructured":"Warkentin, T. E., Sheppard, J.-A.I., Horsewood, P., Simpson, P. J., Moore, J. C., & Kelton, J. G. (2000). Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood, 96, 1703\u20131708.","journal-title":"Blood"},{"key":"9895_CR23","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1182\/blood-2005-11-012450","volume":"108","author":"TE Warkentin","year":"2006","unstructured":"Warkentin, T. E., Sheppard, J.-A.I., Sigouin, C. S., Kohlmann, T., Eichler, P., & Greinacher, A. (2006). Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood, 108, 2937\u20132941.","journal-title":"Blood"},{"key":"9895_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.thromres.2023.07.011","volume":"229","author":"JB Giles","year":"2023","unstructured":"Giles, J. B., Rollin, J., Martinez, K. L., Selleng, K., Thiele, T., Pouplard, C., Sheppard, J. I., Heddle, N. M., Phillips, E. J., Roden, D. M., Gruel, Y., Warkentin, T. E., Greinacher, A., & Karnes, J. H. (2023). Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort study. Thrombosis Research, 229, 198\u2013208.","journal-title":"Thrombosis Research"},{"key":"9895_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","volume":"72","author":"J Kelton","year":"1988","unstructured":"Kelton, J., Sheridan, D., Santos, A., Smith, J., Steeves, K., Smith, C., Brown, C., & Murphy, W. (1988). Heparin-induced thrombocytopenia: Laboratory studies. Blood, 72, 925\u2013930.","journal-title":"Blood"},{"key":"9895_CR26","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1055\/s-0038-1649983","volume":"74","author":"JT Brandt","year":"1995","unstructured":"Brandt, J. T., Isenhart, C. E., Osborne, J. M., Ahmed, A., & Anderson, C. L. (1995). On the role of platelet Fc\u03b3RIIa phenotype in heparin-induced thrombocytopenia. Thrombosis and Haemostasis, 74, 1564\u20131572.","journal-title":"Thrombosis and Haemostasis"},{"key":"9895_CR27","doi-asserted-by":"publisher","first-page":"812830","DOI":"10.3389\/fphar.2021.812830","volume":"12","author":"JB Giles","year":"2022","unstructured":"Giles, J. B., Miller, E. C., Steiner, H. E., & Karnes, J. H. (2022). Elucidation of cellular contributions to heparin-induced thrombocytopenia using omic approaches. Frontiers in Pharmacology, 12, 812830.","journal-title":"Frontiers in Pharmacology"},{"key":"9895_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","volume":"105","author":"L Rauova","year":"2005","unstructured":"Rauova, L., Poncz, M., McKenzie, S. E., Reilly, M. P., Arepally, G., Weisel, J. W., Nagaswami, C., Cines, D. B., & Sachais, B. S. (2005). Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia. Blood, 105, 131\u2013138.","journal-title":"Blood"},{"key":"9895_CR29","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1182\/blood-2007-08-105098","volume":"110","author":"S Suvarna","year":"2007","unstructured":"Suvarna, S., Espinasse, B., Qi, R., Lubica, R., Poncz, M., Cines, D. B., Wiesner, M. R., & Arepally, G. M. (2007). Determinants of PF4\/heparin immunogenicity. Blood, 110, 4253\u20134260.","journal-title":"Blood"},{"key":"9895_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijms.2011.02.003","volume":"303","author":"Y Seo","year":"2011","unstructured":"Seo, Y., Schenauer, M. R., & Leary, J. A. (2011). Biologically relevant metal-cation binding induces conformational changes in heparin oligosaccharides as measured by ion mobility mass spectrometry. International Journal of Mass Spectrometry, 303, 191\u2013198.","journal-title":"International Journal of Mass Spectrometry"},{"key":"9895_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12013-010-9129-5","volume":"59","author":"I Stevic","year":"2011","unstructured":"Stevic, I., Parmar, N., Paredes, N., Berry, L. R., & Chan, A. K. C. (2011). Binding of heparin to metals. Cell Biochemistry and Biophysics, 59, 171\u2013178.","journal-title":"Cell Biochemistry and Biophysics"},{"key":"9895_CR32","doi-asserted-by":"publisher","DOI":"10.19104\/jbtr.2014.101","author":"F Zhang","year":"2014","unstructured":"Zhang, F. (2014). The effects of metal ions on heparin\/heparin sulfate-protein interactions. Journal of Biomedical Technology and Research. https:\/\/doi.org\/10.19104\/jbtr.2014.101","journal-title":"Journal of Biomedical Technology and Research"},{"key":"9895_CR33","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1039\/C8MT00159F","volume":"10","author":"AIS Sobczak","year":"2018","unstructured":"Sobczak, A. I. S., Pitt, S. J., & Stewart, A. J. (2018). Influence of zinc on glycosaminoglycan neutralisation during coagulation. Metallomics, 10, 1180\u20131190.","journal-title":"Metallomics"},{"key":"9895_CR34","doi-asserted-by":"publisher","first-page":"29394","DOI":"10.1074\/jbc.M113.469916","volume":"288","author":"JC Fredenburgh","year":"2013","unstructured":"Fredenburgh, J. C., Leslie, B. A., Stafford, A. R., Lim, T., Chan, H. H., & Weitz, J. I. (2013). Zn2+ mediates high affinity binding of heparin to the \u03b1C domain of fibrinogen. Journal of Biological Chemistry, 288, 29394\u201329402.","journal-title":"Journal of Biological Chemistry"},{"key":"9895_CR35","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1182\/blood-2018-05-850370","volume":"133","author":"K Krauel","year":"2019","unstructured":"Krauel, K., Preu\u00dfe, P., Warkentin, T. E., Trabhardt, C., Brandt, S., Jensch, I., Mandelkow, M., Hammer, E., Hammerschmidt, S., & Greinacher, A. (2019). Fibronectin modulates formation of PF4\/heparin complexes and is a potential factor for reducing risk of developing HIT. Blood, 133, 978\u2013989.","journal-title":"Blood"},{"key":"9895_CR36","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1538-7836.2009.03455.x","volume":"7","author":"D Varga-Szabo","year":"2009","unstructured":"Varga-Szabo, D., Braun, A., & Nieswandt, B. (2009). Calcium signaling in platelets. Journal of Thrombosis and Haemostasis, 7, 1057\u20131066.","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"9895_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1039\/C5MT00064E","volume":"8","author":"BR Watson","year":"2016","unstructured":"Watson, B. R., White, N. A., Taylor, K. A., Howes, J.-M., Malcor, J.-D.M., Bihan, D., Sage, S. O., Farndale, R. W., & Pugh, N. (2016). Zinc is a transmembrane agonist that induces platelet activation in a tyrosine phosphorylation-dependent manner. Metallomics, 8, 91\u2013100.","journal-title":"Metallomics"},{"key":"9895_CR38","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.1038\/s41598-019-47815-z","volume":"9","author":"S Singh","year":"2019","unstructured":"Singh, S., Dodt, J., Volkers, P., Hethershaw, E., Philippou, H., Ivaskevicius, V., Imhof, D., Oldenburg, J., & Biswas, A. (2019). Structure functional insights into calcium binding during the activation of coagulation factor XIII A. Scientific Reports, 9, 11324.","journal-title":"Scientific Reports"},{"key":"9895_CR39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1160\/TH12-07-0465","volume":"109","author":"T Vu","year":"2013","unstructured":"Vu, T., Fredenburgh, J., & Weitz, J. (2013). Zinc: An important cofactor in haemostasis and thrombosis. Thrombosis and Haemostasis, 109, 421\u2013430.","journal-title":"Thrombosis and Haemostasis"},{"key":"9895_CR40","doi-asserted-by":"publisher","first-page":"1197894","DOI":"10.3389\/fimmu.2023.1197894","volume":"14","author":"A Elgheznawy","year":"2023","unstructured":"Elgheznawy, A., \u00d6ftering, P., Englert, M., Mott, K., Kaiser, F., Kusch, C., Gbureck, U., B\u00f6sl, M. R., Schulze, H., Nieswandt, B., V\u00f6gtle, T., & Hermanns, H. M. (2023). Loss of zinc transporters ZIP1 and ZIP3 augments platelet reactivity in response to thrombin and accelerates thrombus formation in vivo. Frontiers in Immunology, 14, 1197894.","journal-title":"Frontiers in Immunology"},{"key":"9895_CR41","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","volume":"4","author":"GK Lo","year":"2006","unstructured":"Lo, G. K., Juhl, D., Warkentin, T. E., Sigouin, C. S., Eichler, P., & Greinacher, A. (2006). Evaluation of pretest clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. Journal of Thrombosis and Haemostasis, 4, 759\u2013765.","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"9895_CR42","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","volume":"2","author":"A Cuker","year":"2018","unstructured":"Cuker, A., Arepally, G. M., Chong, B. H., Cines, D. B., Greinacher, A., Gruel, Y., Linkins, L. A., Rodner, S. B., Selleng, S., Warkentin, T. E., Wex, A., Mustafa, R. A., Morgan, R. L., & Santesso, N. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: Heparin-induced thrombocytopenia. Blood Advances, 2, 3360\u20133392.","journal-title":"Blood Advances"},{"key":"9895_CR43","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/ijerph18052652","volume":"18","author":"T Komarova","year":"2021","unstructured":"Komarova, T., McKeating, D., Perkins, A. V., & Tinggi, U. (2021). Trace element analysis in whole blood and plasma for reference levels in a selected Queensland population, Australia. International Journal of Environmental Research and Public Health, 18, 2652.","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"9895_CR44","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1111\/febs.14986","volume":"286","author":"MP Stelling","year":"2019","unstructured":"Stelling, M. P., Motta, J. M., Mashid, M., Johnson, W. E., Pav\u00e3o, M. S., & Farrell, N. P. (2019). Metal ions and the extracellular matrix in tumor migration. The FEBS Journal, 286, 2950\u20132964.","journal-title":"The FEBS Journal"},{"key":"9895_CR45","volume-title":"Principal component analysis","author":"IT Jolliffe","year":"2002","unstructured":"Jolliffe, I. T., & Jolliffe, I. T. (2002). Principal component analysis. Springer."},{"key":"9895_CR46","first-page":"433","volume":"2","author":"H Abdi","year":"2010","unstructured":"Abdi, H., & Williams, L. J. (2010). Principal component analysis. WIREs. Computational Statistics, 2, 433\u2013459.","journal-title":"Computational Statistics"},{"key":"9895_CR47","doi-asserted-by":"publisher","DOI":"10.5772\/2340","volume-title":"Principal component analysis","author":"P Sanguansat","year":"2012","unstructured":"Sanguansat, P. (2012). Principal component analysis. IntechOpen."},{"key":"9895_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s43586-022-00184-w","volume":"2","author":"M Greenacre","year":"2022","unstructured":"Greenacre, M., Groenen, P. J. F., Hastie, T., D\u2019Enza, A. I., Markos, A., & Tuzhilina, E. (2022). Principal component analysis. Nature Reviews Methods Primers, 2, 100.","journal-title":"Nature Reviews Methods Primers"},{"key":"9895_CR49","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/bib\/bby081","volume":"20","author":"F Abegaz","year":"2018","unstructured":"Abegaz, F., Chaichoompu, K., G\u00e9nin, E., Fardo, D. W., K\u00f6nig, I. R., Mahachie John, J. M., & Van Steen, K. (2018). Principals about principal components in statistical genetics. Briefings in Bioinformatics, 20, 2200\u20132216.","journal-title":"Briefings in Bioinformatics"},{"key":"9895_CR50","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/jat\/bkt046","volume":"37","author":"A Cesbron","year":"2013","unstructured":"Cesbron, A., Saussereau, E., Mahieu, L., Couland, I., Guerbet, M., & Goull\u00e9, J.-P. (2013). Metallic profile of whole blood and plasma in a series of 106 healthy volunteers. Journal of Analytical Toxicology, 37, 401\u2013405.","journal-title":"Journal of Analytical Toxicology"},{"key":"9895_CR51","doi-asserted-by":"publisher","first-page":"13541","DOI":"10.1074\/jbc.272.21.13541","volume":"272","author":"BA Kluszynski","year":"1997","unstructured":"Kluszynski, B. A., Kim, C., & Faulk, W. P. (1997). Zinc as a Cofactor for Heparin Neutralization by Histidine-rich Glycoprotein. Journal of Biological Chemistry, 272, 13541\u201313547.","journal-title":"Journal of Biological Chemistry"},{"key":"9895_CR52","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1538-7836.2009.03735.x","volume":"8","author":"TE Warkentin","year":"2010","unstructured":"Warkentin, T. E., Cook, R. J., Marder, V. J., & Greinacher, A. (2010). Anti-PF4\/heparin antibody formation postorthopedic surgery thromboprophylaxis: The role of non-drug risk factors and evidence for a stoichiometry-based model of immunization. Journal of Thrombosis and Haemostasis, 8, 504\u2013512.","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"9895_CR53","doi-asserted-by":"publisher","first-page":"e62239","DOI":"10.1371\/journal.pone.0062239","volume":"8","author":"D Zhao","year":"2013","unstructured":"Zhao, D., Sun, X., Yao, L., Lin, H., Li, J., Zhao, J., Zhang, Z., Lun, L., Zhang, J., Li, M., Huang, Q., Yang, Y., Jiang, S., Wang, Y., Zhu, H., & Chen, X. (2013). the clinical significance and risk factors of anti-platelet factor 4\/heparin antibody on maintenance hemodialysis patients: A two-year prospective follow-up. PLoS ONE, 8, e62239.","journal-title":"PLoS ONE"},{"key":"9895_CR54","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1182\/blood-2009-07-231506","volume":"115","author":"N Lubenow","year":"2010","unstructured":"Lubenow, N., Hinz, P., Thomaschewski, S., Lietz, T., Vogler, M., Ladwig, A., J\u00fcnger, M., Nauck, M., Schellong, S., Wander, K., Engel, G., Ekkernkamp, A., & Greinacher, A. (2010). The severity of trauma determines the immune response to PF4\/heparin and the frequency of heparin-induced thrombocytopenia. Blood, 115, 1797\u20131803.","journal-title":"Blood"},{"key":"9895_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/2229-5151.119200","volume":"3","author":"AT Gerlach","year":"2013","unstructured":"Gerlach, A. T., Folino, J., Morris, B. N., Murphy, C. V., Stawicki, S. P., & Cook, C. H. (2013). Comparison of heparin dosing based on actual body weight in non-obese, obese and morbidly obese critically ill patients. International Journal of Critical Illness and Injury Science, 3, 195\u2013199.","journal-title":"International Journal of Critical Illness and Injury Science"},{"key":"9895_CR56","doi-asserted-by":"publisher","first-page":"1084511","DOI":"10.3389\/fendo.2023.1084511","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu, J., Qiao, X., Wu, M., Wang, H., Luo, H., Zhang, H., Chen, Y., Sun, J., & Tang, B. (2023). Strategies involving low-molecular-weight heparin for the treatment and prevention of venous thromboembolism in patients with obesity: A systematic review and meta-analysis. Frontiers in Endocrinology, 14, 1084511.","journal-title":"Frontiers in Endocrinology"},{"key":"9895_CR57","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/biom11050689","volume":"11","author":"AA Tinkov","year":"2021","unstructured":"Tinkov, A. A., Bogda\u0144ski, P., Skrypnik, D., Skrypnik, K., Skalny, A. V., Aaseth, J., Skalnaya, M. G., & Suliburska, J. (2021). Trace element and mineral levels in serum, hair, and urine of obese women in relation to body composition, blood pressure, lipid profile, and insulin resistance. Biomolecules, 11, 689.","journal-title":"Biomolecules"},{"key":"9895_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12011-020-02060-8","volume":"198","author":"MJ Rios-Lugo","year":"2020","unstructured":"Rios-Lugo, M. J., Madrigal-Arellano, C., Gayt\u00e1n-Hern\u00e1ndez, D., Hern\u00e1ndez-Mendoza, H., & Romero-Guzm\u00e1n, E. T. (2020). Association of serum zinc levels in overweight and obesity. Biological Trace Element Research, 198, 51\u201357.","journal-title":"Biological Trace Element Research"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-024-09895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-024-09895-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-024-09895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T13:59:25Z","timestamp":1724421565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-024-09895-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["9895"],"URL":"https:\/\/doi.org\/10.1007\/s12012-024-09895-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4385055\/v1","asserted-by":"object"}]},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest to disclose. All authors have reviewed and agreed upon the content of this manuscript and affirm that there are no financial, personal, or professional conflicts that could be perceived as influencing the objectivity of the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}